Laboratory of Neurogenomiks
![Foto de Laboratory of Neurogenomiks](/img/grupo.png)
![Foto de Universidad de Cantabria](/img/noimage_org.png)
Universidad de Cantabria
Santander, EspañaPublikationen in Zusammenarbeit mit Forschern von Universidad de Cantabria (7)
2018
-
Selective up-regulation of cannabinoid CB1 receptor coupling to Go-proteins in suicide victims with mood disorders
Biochemical Pharmacology, Vol. 157, pp. 258-265
2010
-
Long-term fluoxetine treatment modulates cannabinoid type 1 receptor-mediated inhibition of adenylyl cyclase in the rat prefrontal cortex through 5-hydroxytryptamine1A receptor-dependent mechanisms
Molecular Pharmacology, Vol. 77, Núm. 3, pp. 424-434
2007
-
CB1 knockout mice display impaired functionality of 5-HT 1A and 5-HT2A/C receptors
Journal of Neurochemistry, Vol. 103, Núm. 5, pp. 2111-2120
2004
-
A single in-vivo exposure to Δ9THC blocks endocannabinoid-mediated synaptic plasticity
Nature Neuroscience, Vol. 7, Núm. 6, pp. 585-586
-
Influence of age, postmortem delay and freezing storage period on cannabinoid receptor density and functionality in human brain
Neuropharmacology, Vol. 46, Núm. 5, pp. 716-726
2003
-
Ontogenetic development of cannabinoid receptor expression and signal transduction functionality in the human brain
European Journal of Neuroscience, Vol. 17, Núm. 9, pp. 1747-1754
2002
-
Cannabinoid receptor antagonism and inverse agonism in response to SR141716A on cAMP production in human and rat brain
European Journal of Pharmacology, Vol. 443, Núm. 1-3, pp. 43-46